Neuroinflammatory Biomarkers in Cerebrospinal Fluid From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects
Open Access
- 10 April 2022
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 92 (7) , 563-572
Abstract
No abstract availableKeywords
Funding Information
- Lundbeck Foundation (R268-2016-3925)
This publication has 49 references indexed in Scilit:
- Cross-national epidemiology of DSM-IV major depressive episodeBMC Medicine, 2011
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobankingNeurology, 2009
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-AnalysisPsychosomatic Medicine, 2009
- Neurological abnormalities and cognitive ability in first-episode psychosisThe British Journal of Psychiatry, 2008
- Cell index ? a new parameter for the early diagnosis of ventriculostomy (external ventricular drainage)-related ventriculitis in patients with intraventricular hemorrhage?Acta Neurochirurgica, 2004
- Escitalopram dose–response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depressionInternational Journal of Neuropsychopharmacology, 1999
- Blood-Cerebrospinal Fluid Barrier Dysfunction for High Molecular Weight Proteins in Alzheimer Disease and Major DepressionAlzheimer Disease & Associated Disorders, 1997
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960